An Immunogenic Cell Death-Related Gene Signature Reflects Immune Landscape and Predicts Prognosis in Melanoma Independently of BRAF V600E Status

Figure 6

Construction and validation of the ICD-related genes risk model in BRAF V600E WT and mutant SKCM. The distribution of risk score calculated by ICD-related genes prognostic signature and the scatter dot plot shows the association of risk score and survival time in BRAF V600E WT SKCM cohort (a–c) and BRAF V600E mutant SKCM cohort (e–g). The Kaplan-Meier survival curve displays the OS rate of patients with SKCM in low- and high-risk group in BRAF V600E WT cohort (d) and BRAF V600E mutant cohort (h).